- Croda expands its Leek, UK facility to enhance Super Refined™ Poloxamer 188 production.
- The expansion supports bioprocessing applications, focusing on shear-stress protection.
- The project went from ground up to validated production in 15 months.
- New roles in engineering, operations, quality control, and logistics are created.
Facility Expansion
Croda has expanded its Leek, UK site to increase production of its Super Refined™ range, focusing on high purity excipient technology. This expansion is part of Croda's ongoing investments in biopharmaceutical manufacturing, with similar efforts in the USA and Japan.
Super Refined™ Poloxamer 188
The expansion supports the launch of Super Refined™ Poloxamer 188, a highly purified, fast-dissolving granular excipient. This product is engineered for bioprocessing applications, particularly in providing shear-stress protection for cell culture and biopharmaceutical formulations.
Project Timeline
The project progressed from initial groundwork to validated production within 15 months, highlighting the collaboration between Croda's commercial and operational teams.
Job Creation
The facility expansion not only boosts production capabilities but also creates new roles in engineering, operations, quality control, and logistics, demonstrating Croda's commitment to the local economy.
